文献速递膀胱癌与上尿路尿路上皮癌

膀胱癌诊断后第一年的健康相关生活质量:一项纵向调查

Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year.
PubMed 文献 · BJU Int · 2023-12-13

一项英国13家NHS信托机构的前瞻性12个月观察性队列研究,纳入349例新诊断膀胱癌患者,在3、6、9、12个月收集健康相关生活质量(HRQoL)数据,并与全国癌症和一般人群调查比较。接受根治性治疗的患者报告HRQoL较差,包括社会功能较低、疲劳增加和更多未来担忧;经尿道膀胱肿瘤电切术(TURBT)±膀胱内治疗的患者治疗后HRQoL无变化或改善,而根治性治疗队列恶化。

要点

  • 接受TURBT±膀胱内治疗的患者治疗后HRQoL可令其安心。
  • 需要根治性治疗的患者报告HRQoL变化更大,需要适当的临床和支持性护理。
  • 根治性治疗患者较TURBT患者持续报告更差的HRQoL,包括身体形象和男性性功能问题。

核心结论

  • 接受TURBT的患者治疗后HRQoL可令其安心;需要根治性治疗的患者报告HRQoL变化更大,需要适当的临床和支持性护理以尽量减少治疗影响。

研究设计与样本

  • 前瞻性12个月观察性队列研究,在英国13家NHS信托机构纳入新诊断膀胱癌患者,共招募349例,296例(85%)完成基线调查,233例(67%)完成最终调查。

主要发现

  • 基线时,需要根治性治疗的患者较接受TURBT的患者报告更差的HRQoL,包括社会功能较低(74.2 vs 83.8,P=0.002)、疲劳增加(31.5 vs 26.1,P=0.03)和更多未来担忧(39.2 vs 29.4,P=0.005)。
  • 治疗后调查显示,接受TURBT的患者无变化或改善,而根治性治疗队列恶化。
  • 最终调查时,无论治疗如何,报告与基线相似。
  • 根治性治疗患者较TURBT患者持续报告更差的HRQoL,包括身体形象问题(23.4 vs 12.5,P=0.007)和男性性功能问题(75.8 vs 40.4,P<0.001)。
  • 根治性治疗患者报告较低的EQ-5D效用评分和更多日常活动问题,较一般人群。

关键数值与推荐

  • 349例患者中,238例(80%)接受TURBT±膀胱内治疗,51例(17%)接受根治性膀胱切除术/放疗,7例(2%)接受姑息治疗。

临床怎么用

  • 接受TURBT的患者治疗后HRQoL可令其安心;需要根治性治疗的患者报告HRQoL变化更大,需要适当的临床和支持性护理以尽量减少治疗影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the health-related quality of life (HRQoL) of patients in a prospective 12-month observational cohort study of new bladder cancer diagnoses and compare with national cancer and general population surveys. PATIENTS AND METHODS: A prospective UK study in patients with new bladder cancer diagnoses at 13 NHS Trusts. The HRQoL data were collected at 3, 6, 9 and 12 months. Questionnaires used included: the EuroQoL five Dimensions (EQ-5D), European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ)-30-item core, EORTC QLQ-24-item non-muscle-invasive bladder cancer, and EORTC QLQ-30-item muscle-invasive bladder cancer. Results were compared with the Cancer Quality of Life Survey and Health Survey for England. RESULTS: A total of 349 patients were recruited, 296 (85%) completed the first (baseline) and 233 (67%) the final survey. The patients underwent transurethral resection of bladder tumour (TURBT) ± intravesical therapy (238 patients, 80%), radical cystectomy/radiotherapy (51, 17%) or palliation (seven, 2%). At baseline, patients needing radical treatment reported worse HRQoL including lower social function (74.2 vs 83.8, P = 0.002), increased fatigue (31.5 vs 26.1, P = 0.03) and more future worries (39.2 vs 29.4, P = 0.005) than patients who underwent TURBT. Post-treatment surveys showed no change/improvements for patients who underwent TURBT but deterioration for the radically treated cohort. At final survey, reports were similar to baseline, regardless of treatment. Radically treated patients continued to report poorer HRQoL including issues with body image (23.4 vs 12.5, P = 0.007) and male sexual function (75.8 vs 40.4, P < 0.001) compared to those who underwent TURBT. Radically treated patients reported lower EQ-5D utility scores and more problems with usual activities than the general population. DISCUSSION: Patients undergoing TURBT can be reassured regarding HRQoL following treatment. However, those requiring radical treatment report greater changes in HRQoL with the need for appropriate clinical and supportive care to minimise the impact of treatments.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Rogers Z, Glaser A, Catto JWF, et al. Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year. BJU Int. 2023. PMID: 38031657. doi:10.1111/bju.16242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。